Objectives. Our aim was to evaluate the possible association between homocysteine levels and peripheral arterial disease (PAD) in a population-based study of Japanese-Brazilians. Materials and methods. This cross-sectional study was derived from a population-based survey on the prevalence of diabetes and associated diseases conducted in Japanese-Brazilians. A total of 1330 male and female subjects aged ! 30 years were submitted to clinical examination and laboratory procedures including homocysteine measurement. The anklebrachial index (ABI) was calculated; subjects with ABI values <0.9 were diagnosed with PAD. The evaluable population included 1008 subjects. Logistic regression was used taking PAD as the dependent variable. Results. Mean age of the population was 56.5 years and overall prevalence of PAD was 20%. A worse cardiovascular profile was found in male patients, including significantly higher homocysteine levels (11.9 AE 1.8 vs. 9.1 AE 1.1 mmol/L, p < 0.001). Men with PAD had higher prevalence rates of hyperhomocysteinemia compared to women (22.7% vs 7.6%). Univariate analysis showed an odds ratio of hyperhomocysteinemia for PAD of 1.51 [1.02e2.25] in men and 1.69 [1.06e2.68] in women. After adjustment for other cardiovascular risk factors, higher levels of homocysteine were only significantly related to PAD in men. Conclusion. In a Japanese-Brazilian population, elevated levels of homocysteine are associated with PAD in men. Prospective studies are necessary to confirm this finding.
Introduction
The relationship between homocysteine and cardiovascular disorders has been extensively investigated, particularly in coronary and cerebrovascular conditions. More recently, the association between homocysteine levels and peripheral arterial disease has also been highlighted. 6 In 1991, elevated levels of homocysteine were proposed as a novel independent risk factor for atherosclerotic diseases. In a case control study, subjects with coronary, cerebral and/or peripheral atherosclerosis showed elevated total homocysteine (tHcy) levels when compared to controls. 7 However, variable findings were subsequently reported in different populations. A meta-analysis based on 27 observational studies was carried out from 1976 to 1995 by Boushey et al.
The odds ratio (OR) for CAD of a 5 umol/L tHcy increment is 1.6 (95% confidence interval [CI], 1.4 to 1.7) for men and 1.8 (95% CI, 1.3 to 1.9) for women. A total of 10% of the population's CAD risk appears attributable to total homocysteine. The authors concluded that a 5 mmol/L total homocysteine increment elevates CAD risk by as much as cholesterol increases of 0.5 mmol/L (20 mg/dL). 4 Similarly, a prospective study reported a relative risk increment of 1.41 for every 4 mmol/L increase in homocysteine concentration. 8 Our group has conducted a population-based study with Japanese immigrants and their descendants in Brazil, since they have one of the highest prevalence rates of glucose metabolism disturbances worldwide. 9 High prevalence rates of type 2 diabetes, hypertension and dyslipidemia in Japanese immigrants living in the Americas 10, 11 suggest that the exposure to a different lifestyle exacerbated an inherent tendency to accumulate body fat and increase cardiovascular risk factors. More recently, 57% of Japanese-Brazilians were shown to have metabolic syndrome. 12 Therefore, this population represented an opportunity to investigate the possible relationship between newly identified risk factors, such as circulating levels of homocysteine, and atherosclerotic cardiovascular diseases. Data collected in 2000 from the Japanese-Brazilian population aged !30 years included Doppler of the extremities and a number of laboratory tests.
Our aim was to investigate whether elevated levels of homocysteine were independently associated with peripheral arterial disease in this population of Japanese-Brazilians with high cardiovascular risk.
Methods
A survey was conducted in a population of first (Japan-born) and second-generation Japanese-Brazilians living in Bauru, São Paulo, Brazil, to estimate the prevalence of diabetes and associated diseases. The data used subsequently in this analysis belong to the second phase of the survey, conducted in 2000. All the patients, male and female, !30 years of age were invited to participate. Details on the selection and recruitment of the sample population have been previously described. 13 The Institutional Ethics Committee approved the study, and informed consent was obtained from all the subjects. A total of 1330 subjects were interviewed at home by trained interviewers, using standardized health and nutritional status questionnaires, and were scheduled for clinical and laboratory procedures. Data on smoking status (non-smoker, current or previous smokers, i.e. subjects who had smoked 5 or more cigarettes a day for at least 12 months) and past medical history were recorded.
The clinical examination included anthropometric measurements. Body mass index, determined by the weight (kilograms) divided by the square of the height (meters); waist circumference was measured at the umbilicus level. Blood pressure was taken after 5 minutes rest in the sitting position, with an automatic device (Omron model HEM-712C, Omron Health Care, Inc, USA). The mean of the last 2 measurements was used to express systolic and diastolic blood pressure values. Fasting blood samples were taken for several tests. Non-diabetic and self-reported diabetic subjects with fasting capillary glucose <200 mg/dL, screened with glucose-oxidase strips, were submitted to a 75-gram oral glucose tolerance test.
Conventional risk factors
Generalized and central obesity was defined according to WHO criteria for Asian subjects. 14 The cutoffs of waist circumference for Asian populations were 90 cm for men and 80 cm for women. Hypertension was defined by systolic/diastolic blood pressure ! 140/90 mmHg or use of antihypertensive medications. The diagnosis of dyslipidemia was based on the Third Report of the National Cholesterol Education Program e ATP III. 15 Hyperuricemia was defined as uric acid values above 7 mg/dL for men and 6 mg/dL for women. 16 Glucose tolerance status was based on 1999 WHO criteria. 17 
Peripheral arterial disease diagnosis
The transcutaneous blood velocity detector used was the Imbracios-8MHz Doppler. Initially, brachial occlusion pressure was recorded in the supine position with the Doppler probe placed over the brachial artery at the elbow. The measurement was taken in both arms and the highest value was retained. Then, ankle occlusion pressure was recorded with the pencil probe placed on the anterior and posterior tibial arteries. The ankle-brachial index was determined in both extremities. An index below 0.90 indicated flow-limiting stenosis in the examined leg 18 and established the diagnosis of PAD. Subjects with chronic renal failure (serum creatinine > 1.6 mg/dL or clearance of 60 mL/min), 19 or without complete clinical examination, laboratory profile or ankle-brachial index data were excluded. Therefore, data from 1008 participants (459 men and 549 women) were analyzed.
Analytical methods
Plasma glucose, creatinine and uric acid concentration were determined by routine methods. Cholesterol lipoprotein fractions and triglycerides were measured by enzymatic methods in automatic analyzers. Homocysteine was determined by high performance liquid chromatography, as described by Pfeiffer et al.
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(normal range: 5e15 mmol/L) and detected by a fluorimetric method. Plasma homocysteine levels exceeding 15 mmol/L were considered to be elevated. 21 Sera were stored at À70 C.
Statistical analysis
Data were reported as mean and standard deviation for numerical variables or number and percent for categorical variables. Unpaired Student's t test was used to compare means of clinical and laboratory data between subgroups stratified by gender. Chi-square test was used for comparisons of frequencies. Nonconditional logistic regression analysis was applied, taking PAD as the dependent variable and hyperhomocysteinemia as the independent variable of main interest, adjusted for a number of categorical variables (conventional risk factors). Those variables with a p value 0.20 in the crude analysis were selected for the multivariate analysis. Distinct models were built for each gender. Results were expressed as odds ratios and 95% confidence intervals. The initial model for men included age (continuous variable), smoking habit (non-smoker, former or current smoker), glucose tolerance status and systemic hypertension, in addition to hyperhomocysteinemia; for women, dyslipidemia and hyperuricemia were also included. The level of significance was set at alpha ¼ 0.05. Data analyses were performed using STATA 7.0.
Results
The mean age of the 1008 Japanese-Brazilian subjects studied (46% male) was 56.5 years. Sixty-two percent of the population was in the 50e69 years age group; both genders had similar age distribution ( Table 1) .
The mean values of body mass index, waist circumference, blood pressure, fasting and 2-hour plasma glucose, HDL-cholesterol, triglycerides, uric acid and homocysteine were significantly higher in male subjects. Table 2 shows the prevalence rates of conventional risk factors and of hyperhomocysteinemia in JapaneseBrazilian men and women.
The prevalence of PAD was estimated at 20.4% (95% CI [18.0%;23.1%]) for the total population and no difference was found between genders (19.1% vs. 20.7%, p ¼ 0.529). The odds ratio for PAD per cardiovascular risk factor is presented in Table 3 .
Univariate analysis showed higher OR for PAD in former or active smoker versus non-smoker male subjects ( p < 0.05) ( Table 3 ). In female subjects aged ! 60 years, the presence of hypertension, diabetes, hypercholesterolemia, and hypertriglyceridemia was significantly associated with increased risk of PAD. Hyperhomocysteinemia also increased the risk of PAD in both genders (OR 1.51 and 1.69, respectively, for men and women, p < 0.05).
The logistic regression model for males showed that PAD was independently associated with age, smoking habit (former and current) and hyperhomocysteinemia (Table 4 ). The risk of developing Data expressed as means and standard deviation (in parenthesis). In female subjects, the logistic regression analysis also detected an independent association between age (p ¼ 0.04) and hypertension (p ¼ 0.01) with PAD (Table 5) .
Discussion
A high prevalence of PAD (20.4%) was detected in this population-based study of Japanese-Brazilian subjects. Considering that this population has one of the highest prevalence rates of diabetes worldwide 12 as well as of other conventional cardiovascular risk factors, 8, 22, 23 they are also expected to have a high prevalence of atherosclerotic disease.
The ankle-brachial index has been widely used as the diagnostic tool for PAD. 18,24e27 In the Limburg's study, using the same methodology, Stoffers et al. 28 found a lower prevalence of PAD (6.1%) than in our study, and could not detect differences in rates between genders. Our data agree with those from the Rotterdam study, where prevalence rates were approximately 17% in male and 20% in female subjects above age 55. 26 More recent data from the National Health and Nutrition Examination Survey 29 found PAD was present in 4.3% of the North American population above 40 years and in 14.5% above 70 years. Murabito et al. 30 found similar data analyzing 1554 men and 1759 women included in the Framingham study. Using the ankle-brachial index for diagnosing PAD, their prevalence rate was 3.9% in men and 3.3% in women. Despite these lower rates, again there was no difference between genders. The high incidence of conventional risk factors in both genders might contribute to similar rates of PAD in JapaneseBrazilian men and women.
Using multivariate analysis, we found a number of risk factors associated with PAD for each gender. Age was associated with PAD in men and women. Smoking and hyperhomocysteinemia were only associated with PAD in men. In fact, the prevalence of smoking among women was low. Even with the low prevalence of smoking among women, we found a similar prevalence of PAD in both sexes; therefore, the high prevalence of PAD in women may be Homocysteine concentration, as well as the prevalence of hyperhomocysteinemia, were lower in Japanese-Brazilian women than in men. These findings are similar to those obtained in a smaller study, including 32 women and 29 men with PAD. 31 The investigators found significantly higher levels of homocysteine among men (18.3 mmol/L) as compared to women (15.3 mmol/L). No association between PAD and hyperhomocysteinemia in the female subjects was also demonstrated in another investigation. 32 Loncar et al. 33 compared homocysteine levels of 40 subjects with PAD and 40 healthy volunteers, and found higher mean values in affected subjects (14.8 mmol/L vs 11.3 mmol/L). Differences in homocysteine concentrations between genders were observed in the control group, with significantly higher values in healthy men than in healthy women (12. 05 mmol/L vs 9.63 mmol/L). Such influence of gender on homocysteine levels was first described by Cacan et al. 34 in a healthy study population; mean values of 9.7 mmol/L in men were shown to be significantly higher than in women (7.6 mmol/L). A plausible explanation for this difference was proposed by Dierkes et al. 35 who suggested that high levels of estradiol and low percentage of lean body mass could contribute to lower homocysteine levels in female subjects.
We defined hyperhomocysteinemia as plasma homocysteine levels above 15 mmol/L. We did not consider the influence of gender on homocysteine levels, which may have interfered with the low prevalence of female hyperhomocysteinemia. In our crosssectional study, the prevalence of PAD in JapaneseBrazilian men increased 3% for each 1 mmol/L elevation in homocysteine concentration. These data are similar to those reported in the Homocysteine and Progression of Atherosclerosis Study. 36 This prospective study concluded that an elevation of 1 mmol/L in serum homocysteine increased by 3.6% the risk of death from PAD. A recent review 37 confirmed that the odds ratio for PAD in subjects with hyperhomocysteinemia varies considerably, ranging from 2.0 to 11.0.
Clarke et al. 7 were the first to report that hyperhomocysteinemia could be an independent risk factor for atherosclerosis. In subjects with hyperhomocysteinemia, they found different odds ratios, depending on the arterial territory studied: 1.52 for extracranial carotid-artery, 1.40 for coronary artery and 1.13 for peripheral arteries. The hypothesis that hyperhomocysteinemia could be a novel atherosclerotic risk factor was contested by Valentine et al., 38 who did not find any difference in homocysteine values comparing young men with and without PAD. The Nutrition Examination Survey (NHANES), 39 a cross-sectional study, evaluated the roles of traditional and non traditional risk factors, including lead and cadmium exposure, in confounding the association between homocysteine and reduced anklebrachial index. The findings indicate that previous studies may have overestimated the association between homocysteine and PAD. Adjustment for blood lead and cadmium and for smoking completely eliminated the association of homocysteine with PAD. On the contrary, our study found independent associations of homocysteine and smoking with PAD in men.
In conclusion, our data supports an independent association of PAD and hyperhomocysteinemia in Japanese-Brazilian male subjects. The study design does not allow a causal relationship to be assigned. To find out if an elevated homocysteine level represents an additional risk factor for this population, prospective studies are required, perhaps considering different normal ranges for men and women.
